Artificial intelligence for diabetic retinopathy screening: a review

Diabetes is a global eye health issue. Given the rising in diabetes prevalence and ageing population, this poses significant challenge to perform diabetic retinopathy (DR) screening for these patients. Artificial intelligence (AI) using machine learning and deep learning have been adopted by various...

Full description

Saved in:
Bibliographic Details
Published in:Eye (London) 2020-03, Vol.34 (3), p.451-460
Main Authors: Grzybowski, Andrzej, Brona, Piotr, Lim, Gilbert, Ruamviboonsuk, Paisan, Tan, Gavin S W, Abramoff, Michael, Ting, Daniel S W
Format: Article
Language:English
Subjects:
Aging
Algorithms
Artificial Intelligence
Deep learning
Diabetes
Diabetes Mellitus
Diabetic retinopathy
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - epidemiology
Humans
Learning algorithms
Machine Learning
Mass Screening
Retinopathy
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diabetes is a global eye health issue. Given the rising in diabetes prevalence and ageing population, this poses significant challenge to perform diabetic retinopathy (DR) screening for these patients. Artificial intelligence (AI) using machine learning and deep learning have been adopted by various groups to develop automated DR detection algorithms. This article aims to describe the state-of-art AI DR screening technologies that have been described in the literature, some of which are already commercially available. All these technologies were designed using different training datasets and technical methodologies. Although many groups have published robust diagnostic performance of the AI algorithms for DR screening, future research is required to address several challenges, for examples medicolegal implications, ethics, and clinical deployment model in order to expedite the translation of these novel technologies into the healthcare setting.
ISSN:0950-222X
1476-5454
DOI:10.1038/s41433-019-0566-0